0001209191-18-059044.txt : 20181116
0001209191-18-059044.hdr.sgml : 20181116
20181116175638
ACCESSION NUMBER: 0001209191-18-059044
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181116
FILED AS OF DATE: 20181116
DATE AS OF CHANGE: 20181116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Levy Howard
CENTRAL INDEX KEY: 0001672333
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51173
FILM NUMBER: 181190867
MAIL ADDRESS:
STREET 1: 260 LITTLEFIELD AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CATALYST BIOSCIENCES, INC.
CENTRAL INDEX KEY: 0001124105
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 562020050
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 260 LITTLEFIELD AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 6507450655
MAIL ADDRESS:
STREET 1: 260 LITTLEFIELD AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: TARGACEPT INC
DATE OF NAME CHANGE: 20000919
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-11-16
0
0001124105
CATALYST BIOSCIENCES, INC.
CBIO
0001672333
Levy Howard
611 GATEWAY BOULEVARD, SUITE 710
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Medical Officer
Common Stock
2018-11-16
4
M
0
173
4.63
A
7733
D
Common Stock
2018-11-16
4
S
0
173
11.00
D
7560
D
Stock Option (Right to Buy)
4.63
2018-11-16
4
M
0
173
0.00
D
2027-07-11
Common Stock
173
87267
D
Sale of shares made pursuant to and in accordance with the requirements of Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, under a plan adopted by the Reporting Person on September 5, 2018.
The Option vests monthly over a period of four years commencing June 15, 2017.
/s/ Faisal Shawwa Attorney-in-Fact for Howard Levy
2018-11-16